INS and type 2 diabetes mellitus: Experimental and clinical evidence suggests that, during the early stages of the onset of type 2 diabetes mellitus (T2DM), the β-cell works diligently to increase the biosynthesis and release of insulin to compensate for insulin resistance in the target peripheral tissues.